(Q79206962)
Statements
Short-schedule intravesical gemcitabine with ablative intent in recurrent Ta-T1, G1-G2, low- or intermediate-risk, transitional cell carcinoma of the bladder (English)
Massimo Maffezzini
Fabio Campodonico
Giorgio Canepa
Giacomo Capponi
Vincenzo Fontana
20 September 2006